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ABSTRACT
Introduction: Patients beneﬁt from early and intensive
treatment in both acute ischaemic stroke and transient
ischaemic attack. Recent audits of acute stroke/
transient ischaemic attack care suggest that although
standards have improved, current services still fall
short of optimal care. The aim of this study is to
establish a database of patients accessing stroke
services. Data will be collected and analysed to provide
individualised feedback to healthcare professionals
who can then use these ﬁndings to develop strategies
for service improvement.
Methods and analysis: This longitudinal
observational study will evolve with the ongoing
ﬁndings from the research output. The project will
consist of three phases: assessment of current
practice, feedback of ﬁndings and evaluation of
service change. Consecutive patients will be
recruited from participating hospitals, and
identiﬁable data will be collected to link records from
the Primary Care, Secondary Care and Emergency
Services. As this study focuses on observation
of current practice, a sample size calculation is
not deemed appropriate. Patients will be sent
follow-up questionnaires examining quality of life at
3 and 12 months post-event. Qualitative interviews
will examine the care pathway through the
experiences of patients, their carers, healthcare
personnel and commissioners. Collected data will be
used in economic analyses, which will evaluate the
impact of current care and service redesign on the
NHS costs and patient outcomes (death and quality
of life).
Ethics and dissemination: Ethical approval for this
study has been obtained from the National Research
Ethics Committee (reference; 09/H0716/71), and site-
speciﬁc R&D approval has been acquired from the
relevant NHS trusts. All ﬁndings will be presented at
relevant healthcare/academic conferences and written
up for publication in peer-reviewed journals. Results
will be fed back to patients and participating trusts
through a series of reports and presentations. These
will be used to facilitate discussions about service
redesign and implementation.
BACKGROUND
Stroke is one of the leading causes of
morbidity and mortality worldwide, with an
estimated 5.7 million deaths and 50 million
disability-adjusted life-years lost every year.
1
To this end, stroke-related mortality is
expected to rise by 37% in the next 20 years.
1
Effective diagnosis and management of
stroke and transient ischaemic attack (TIA) is
therefore of importance.
It is now well recognised that people who
have a stroke or TIA beneﬁt from early
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ARTICLE SUMMARY
Article focus
- Optimising the management of stroke and
transient ischaemic attack (TIA).
- Study protocol using a mixed-methods approach.
Key messages
- Stroke and TIA are not currently managed
effectively across the care pathway.
- This project will collect patient data across the
care pathway from multiple NHS trusts.
- A model of research, feedback and evaluation will
be adopted.
Strengths and limitations of this study
- Combining data collection from multiple health-
care settings with economic evaluations will
provide a unique insight into stroke and TIA
management across the care pathway.
- The need to obtain informed consent from
patients to allow data linkage may limit the
completeness of the data.
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Open Access Protocolintensive treatment: in acute ischaemic stroke, throm-
bolysis within 3 h of symptom onset results in improved
outcomes
2 and has thus been recommended by the
National Institute for Health and Clinical Excellence.
3
Indeed, this has now been extended to 4.5 h following
observational data suggesting beneﬁt from thrombolysis
past the original time window.
4 Similarly, people having
a TIA are at high risk of having a subsequent stroke;
these risks are highest in the ﬁrst few days following the
event.
5 There are several interventions, both medical
and surgical, that can substantially reduce this risk of
stroke following a TIA, and evidence that earlier inter-
vention is better.
6
To ensure that patients with stroke and TIA receive
diagnosis and treatment quickly, national guidelines
recommend that services be designed to include
a combination of emergency referral, early brain
imaging and thrombolysis in acute stroke and immediate
referral for urgent specialist assessment and investiga-
tion in TIA.
6 7 The National Sentinel Stroke Audit
reveals that although standards have improved, current
care still falls short of these aspirations: in 2010, only 5%
of patients received thrombolysis for acute stroke.
8 For
TIA services, care has improved with specialist review
following TIA occurring within 7 days in 97% of high-
risk patients and 86% of low-risk patients.
9 However,
this still falls short of the 100% speciﬁed in clinical
guidelines.
The National Sentinel Stroke Audit
8 is a useful tool for
assessing current hospital stroke services across the
country. However, this includes a small proportion of the
total patients and cannot assess the whole care pathway
for patients with acute stroke and TIA. Pre- and post-
event management in Primary Care and via Emergency
Services may have a signiﬁcant impact on stroke and
other cardiovascular events,
10 hence effective preho-
spital care is vital in achieving the standards set out in
the National Stroke Strategy.
7 Currently, it is not clear to
what extent the interaction between services impacts
patient care and outcomes.
The aim of this project is to identify barriers to effec-
tive treatments and model the impact of service change
on patient outcomes and NHS costs using data collected
from the Primary Care, Secondary Care and Emergency
Services. In addition, qualitative interviews and focus
groups will establish the view of patients, their carers,
healthcare personnel and commissioners towards
current stroke and TIA care.
This work is part of the National Institute for Health
Research, Collaborations for Leadership in Applied
Health Research and Care(CLAHRC) programme. The
main remit of this funding stream is to close the current
gap between research and clinical practice.
11 12 As
a result, a unique aspect of this project will be to
combine research ﬁndings with routinely collected data
in economic models and provide feedback to healthcare
professionals and commissioners, working with them to
develop strategies for change. This project will result in
more detailed information on stroke and TIA services
than ever before along with speciﬁc plans for service
development underpinned by reliable cost-effectiveness
data. Evaluation will assess the gap between research and
clinical practice and provide a model for future research
into service improvement in the NHS.
METHODS
Study aims/research questions
The overriding aim of this study is to optimise the
acute management of people with stroke and TIA in
Birmingham through identiﬁcation and breaking down
of current barriers to timely and effective treatment. The
project involves an iterative process beginning with
observation of current practice. From this initial obser-
vation, the following research questions have been
formulated:
1. How do stroke and TIA patients get to hospital and
why do they choose these routes?
2. To what extent does prehospital and hyperacute
hospital care impact the timeliness of subsequent
treatment, especially thrombolysis?
3. Are risk factors for cardiovascular disease correctly
measured and managed in Primary Care before and
after stroke or TIA?
4. What impact would service redesign to increase the
proportion of acute stroke patients receiving throm-
bolysis have on the cost-effectiveness of care and
patient outcomes in terms of strokes averted and
quality-adjusted life-years?
5. What are the queuing effects caused by intermittent
TIA clinics and what impact would a move to clinic
slots, 7 days a week, have on patient outcomes and
cost-effectiveness?
6. What do patients (and their carers) see as positive or
negative aspects of the acute stroke patient pathway?
7. How do patient perspectives differ from those of the
healthcare personnel working in the stroke pathway?
These research questions will be answered using
a mixed-methods approach, bringing together quanti-
tative, qualitative and economic analyses. A major goal of
the work is to integrate with the healthcare service in
which the research is conducted, building lasting rela-
tionships that reduce the existing gaps between research
and implementation.
11 12 Using this model will enable
further research questions to be generated in conjunc-
tion with the healthcare providers, ensuring that they are
timely and relevant.
Study design
This is a longitudinal observational study of stroke and
TIA management throughout the care pathway. The
study will employ the Plan-Do-Study-Act cycles of imple-
mentation and evaluation.
13 This model is commonly
used in quality improvement projects
14e16 and will be
adapted for this project into three phases: assessment of
current practice (recruitment of study participants and
data collection), feedback (reporting of research
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Optimisation of the management of stroke and transient ischaemic attackﬁndings directly to service providers) and evaluation (of
ongoing service change through further recruitment and
data collection) (ﬁgure 1). Recruitment and collection of
data relating to stroke and TIA services, respectively, will
be staggered to ensure resources are used effectively.
Ethical considerations
Although this study primarily involves service evaluation,
ethical approval is required to allow collection of patient
identiﬁers and sending out of quality-of-life question-
naires. Therefore, full ethical approval has been
obtained from the National Research Ethics Service
Committee, LondondQueen Square (reference; 09/
H0716/71) and site-speciﬁc R&D approval has been
acquired from the relevant NHS trusts. In addition,
participating trusts have given approval for anonymised
data from clinical audits to be used within the quanti-
tative analyses in this project.
Study population/recruitment procedure
The study will take place within two hospital trusts
(University Hospitals Birmingham NHS Foundation
Trust and Heart of England NHS Foundation Trust)
and the surrounding Primary Care Trusts (South
Birmingham, Birmingham East and North, Solihull,
Sandwell, Dudley, Heart of Birmingham Teaching,
Warwickshire, Worcestershire). Additional data relating
to patients who travelled to hospital via ambulance will
be collected from the West Midlands Ambulance Service
NHS Trust (ﬁgure 2).
Patients will be recruited from stroke wards and TIA
clinics in participating hospital trusts. Eligible patients
will be those thought to be having a stroke or TIA who
present to a collaborating hospital trust and are under
the care of a participating stroke consultant during the
data collection period (ﬁgure 2). Only patients unwilling
or unable to give informed consent (and where no
consultee is available) will be excluded. Informed
consent will be gained from all patients to allow collec-
tion of patient identiﬁers and completion of quality-of-
life questionnaires. Where an individual is unable to
provide informed consent due to lack of capacity, assent
from an appropriate consultee will be sought.
Patients eligible for the qualitative component of the
project will be selected from those recruited to the main
study. Purposive sampling will be used in recruitment to
ensure that a range of patient experiences is captured.
Patients will be given the option of having their carer,
friend or family member attend the interview with them
and they can refer to them in order to help ﬁll in the
gaps in their accounts. All parties attending interviews
will provide written informed consent.
Figure 1 Project timeline
detailing phases and related
activity throughout the project.
Figure 2 Flow diagram of patient recruitment and data
collection during the study. MRIS, Medical Research
Information Service; TIA, transient ischaemic attack.
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Optimisation of the management of stroke and transient ischaemic attackHealthcare personnel and commissioners will be
interviewed, either on their own or in a focus group.
Purposive sampling will be used to ensure recruitment
of personnel across the care pathway, with study stake-
holders acting as gatekeepers to recruit initial
participants.
Sample size
No formal sample size calculation has been taken for this
project. The nature of this study is that it is one of
observation of current practice, and therefore, a sample
size calculation was not deemed appropriate. However,
based on validated data from both hospital trusts
(2010e2011), approximately 400 patients with stroke
and 350 patients with TIA attended each hospital each
year. Based on our model of two 1-year data collection
periods (the ﬁrst being assessment of current practice
and the second being an evaluation of practice change)
(ﬁgure 1) and assuming around 75% recruitment of
eligible patients, approximately 600 patients with stroke
and 525 patients with TIA will be included per data
collection period.
Within the qualitative component, interviews will be
conducted with approximately 30 patients (some of
whom will be accompanied by their carers). When
10 and 20 patients have been interviewed, a further
theoretical sample will be sought,
17 guided by the
emerging data analysis in order to extend and challenge
earlier data and interpretation and to test the integrity
and credibility of the developing analysis.
18 The
proposed number of interviews will enable saturation of
themes.
19 20 Healthcare professionals and commis-
sioners will be selected in a similar vein, with up to 30
per stakeholder group.
Data collection
Data related to the patient’s present hospital admission/
clinic appointment and preceding stroke/TIA event will
be collected retrospectively from hospital medical
records (table 1). Patient identiﬁers will be collected to
allow identiﬁcation of patient records in other partici-
pating NHS trusts.
General practitioner surgeries from the participating
Primary Care Trusts will be invited to participate in the
Table 1 Quantitative data collected from each healthcare setting
Healthcare setting Time period* Data collected Examples
Primary Care Pre- and
post-stroke/
TIA event
Measurement of
cardiovascular
risk factors
Blood pressure, cholesterol, smoking status,
absolute cardiovascular risk score
Management of
cardiovascular
risk factors
Antihypertensive and statin prescriptions
Dates and times Relating to GP consultations, cardiovascular
risk factor measurements, prescriptions
Secondary Care During stroke/
TIA event
Patient identiﬁers NHS number, patient name, date of birth and
patient address
Route to hospital Emergency ambulance, general practitioner
referral, self referral to the emergency department
Inhospital
investigations
CT scan, blood pressure, cholesterol
Treatment given Thrombolysis, carotid endarterectomy
Dates and times Relating to onset of symptoms, arrival in hospital,
CT scan, ﬁrst contact with medical/health
professionals, admission to hospital, discharge
from hospital, follow-up clinic appointment
Discharge medication Antihypertensive and statin prescriptions
Final diagnosis Stroke, TIA, stroke mimic
Emergency
Services
Pre-stroke/
TIA event
Presenting complaint Suspected stroke, TIA, left-sided weakness
Patient symptoms Arm weakness, speech impediment, dizziness
Emergency service
investigations
Face Arm Speech Test, blood pressure,
heart rate, Glasgow Coma Score
Medications
administered
Saline solution (NaCl)
Dates and times Relating to onset of symptoms, ambulance
dispatch, arrival at patient, departure for hospital,
arrival in the emergency department and
handover of patient care
Medical Research
Information Service
Post-stroke/
TIA event
Date and time Of death
Cause of death As stated on death certiﬁcate
*Time period (in relation to the patient’s stroke/TIA event) from which data were collected.
GP, General Practitioner; TIA, transient ischaemic attack.
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Optimisation of the management of stroke and transient ischaemic attackstudy, and data will be collected regarding Primary Care
consultations, including primary and secondary preven-
tion and outcome (table 1).
For those patients who travel to hospital via the
Emergency Services, data will be extracted from the West
Midlands Ambulance Service NHS Trust records. Rele-
vant patient data will be identiﬁed using ambulance case
and station numbers, extracted from hospital records.
Data collected will include details of presenting
complaints, patient symptoms, investigations conducted
(eg, Face Arm Speech Test) and medications given
(table 1). Timings from ambulance dispatch to arrival at
hospital and handover will be acquired from the ambu-
lance computer-aided dispatch system.
Additional anonymised data will be collected from all
participating hospital trusts. These data will include
demographics for all validated stroke admissions during
each data collection period. This will be used to deﬁne
the proportion of eligible patients successfully recruited
to the study and whether these patients are representa-
tive of the general stroke population. Additional data
regarding all scheduled TIA follow-up clinics will also be
collected from both hospital sites for use in economic
analyses.
Data from each NHS trust will be securely transferred
into a bespoke web enabled SQL server database
(Microsoft Corporation, Redmond, Washington, USA)
stored securely at the host institution (University of
Birmingham).
Qualitative data will be collected via in-depth interview
or focus group. In-depth interviews will be used as they
offer the most appropriate way to elicit people’s beliefs
and experiences.
21 22 Focus groups provide an oppor-
tunity for interaction between participants, allowing
them to reﬂect on their own and others perspectives.
23
Flexibility in data collection is required to enable as
broad a range of people to participate as possible, for
example, focus groups are more appropriate in some of
the healthcare environments.
Interviews and focus groups will follow a topic guide,
developed iteratively as the study progresses.
24 Data will
be collected from patients (and their carers) about their
stroke and TIA experience and their treatment and care
in relation to this. Healthcare personnel and commis-
sioners will be asked about the stroke and TIA patient
pathways, in particular, areas they think are good or that
could be improved.
Following interviews and focus groups, the interviewer
will write ﬁeld notes,
25 noting the context and ‘feel’ of
the interview (eg, if there were any points at which the
participant was uncomfortable). Non-verbal communi-
cation will also be recorded in this. These ﬁeld notes will
be used in conjunction with interview transcripts during
data analysis.
Follow-up
Postal questionnaires will be sent to all recruited patients
(who are still alive) at 3 and 12 months after the initial
stroke/TIA event. These questionnaires will contain
health status assessments, including the Modiﬁed
Rankin Score, EQ-5D and the Stroke Impact Scale.
Patients’ vital status will be checked using the NHS
Personal Demographics Service, 1 week prior to sending
the questionnaire.
Details of all recruited patients will be sent to the
Medical Research Information Service at the NHS
Information Centre (Leeds, England). They will provide
quarterly follow-up data on all-cause mortality for all
patients in the study (table 1).
DATA ANALYSIS AND DISSEMINATION
Epidemiological study
Quantitative data from all trusts will be collated and
analysed to assess existing barriers to effective treatment
for stroke and TIA. Previous literature assessing barriers
to effective acute stroke care have focused primarily on
public awareness
26 27 and hospital care.
28e30 The main
focus of our analyses will be to use linked data from each
patient to assess the impact of care across the clinical
pathway (hence across clinical organisations), something
that is not currently possible with routine clinical audits
in the UK.
8 Descriptive statistics will be used to deﬁne
current practice, and logistic regression analyses will
evaluate associations between identiﬁed barriers to care
and other inﬂuencing factors.
Epidemiological ﬁndings will be used to inform
proposed strategies for change in the economic analyses
of the stroke and TIA care pathway. In addition, trust-
speciﬁc ﬁndings will be reported back to relevant parties
through a series of tailored reports and presentations.
This dissemination will offer a unique opportunity to
feedback ﬁndings between trusts and facilitate joined-up
service provision.
Economic modelling study
In acute stroke, previous economic analyses have
assessed the effects of thrombolysis against ‘conservative
treatment’ (no thrombolysis).
31e34 In the present study,
we intend to compare current care (including throm-
bolysis) with ‘change strategies’ designed to increase
thrombolysis rates. Following the feedback phase of the
project (ﬁgure 1), we will use the same modelling
approach to examine whether ongoing service change
has been effective.
Through work previously commissioned by the West
Midlands Strategic Health Authority, a mathematical
model has been developed that compares current prac-
tice with service redesign. This decision tree model maps
out the acute stroke care pathway, using a series of
probabilities (derived from epidemiological data
collected), which predicts the likelihood a patient will
access a speciﬁc service or be given a type of treatment.
The model will be used to evaluate the impact of treat-
ment decisions on NHS costs and patient outcomes
(death and quality of life). These costs will be derived
from a combination of standard unit costs, NHS refer-
ence costs and previously published literature.
31 35
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Optimisation of the management of stroke and transient ischaemic attackHealth status data will be collected directly from patients
using 3- and 12-month follow-up questionnaires and
supplemented with published data.
31
Our group has also previously developed a mathemat-
ical model, which aims to determine the optimum
pattern of service provision for people presenting with
a TIA or minor stroke.
36 This discrete event simulation
model examines the workload and cost implications of
various methods of organising care. In the present study,
the model will be used to track individuals who are
occasionally competing for resources in a realistic
representation of calendar time (the availability of these
resources depends on time of day and day of week). This
will allow estimation of the impact of redesigning TIA
services on NHS costs and patient outcomes. Once
again, the model will be based on real-life data collected
from recruited patients and anonymised data from the
hospital trusts.
Economic modelling is relevant in this situation as it
allows comparison of different patterns of service provi-
sion in a systematic fashion where trial comparison
would be impracticable. The ﬁndings of these studies
will be fed back to participating trusts through reports
and presentations. Speciﬁcally, service commissioners
will be engaged, and these data will be central to future
commissioning of stroke services across the participating
Trusts.
Qualitative study
Qualitative methodologies offer the most appropriate
way to elicit people’s beliefs, knowledge and the mean-
ings they ascribe to their experiences.
21 22 In this study,
these methodologies will be used to examine what
barriers to service delivery, implementation and use,
patients and healthcare professionals experience along
the stroke and TIA care pathway.
Interview transcripts will be read and checked for
accuracy and then entered into a computerised database
using the NVivo software package (QSR International
Pty Ltd, Doncaster, Victoria, Australia). Data analysis will
be conducted using constant comparative analysis, with
examination of deviant cases.
37 38 Coding processes,
including creating OSOPs,
24 will identify emerging key
categories and concepts from the participant data. These
will be compared across interviews and time of data
collection in order to capture the process of change.
Concepts identiﬁed will further be compared against
established concepts in the literature and will be inte-
grated into themes providing a structure for presenta-
tion of ﬁndings. Researchers from a number of
disciplines (sociology, public health, nursing and
primary care) will be involved in the analysis, allowing
for a range of insights to be gained.
24 Other steps to
ensure rigour will include: having two (or more)
researchers independently code initial transcripts and
then compare ﬁndings to formulate an initial coding
frame.
Findings will be fed back to participating trusts in
conjunction with epidemiological and economic
modelling feedback. This qualitative element of the
project will offer a unique insight to the overall study
ﬁndings and facilitate service redesign, which is better
tailored to patient and practitioner needs.
CONCLUSIONS
The CLAHRC Optimisation of the Management of
Stroke and TIA project will build on previous work by
describing current practice in stroke and TIA care
8 9 and
examine the potential effects of implementation of the
National Stroke Strategy.
7 By working together with
multiple healthcare trusts, this study aims to improve
patient care right across the stroke and TIA care
pathway. Using a generalisable model, data collection,
analysis, feedback and evaluation will be carried out
within the life of this project. This model of research,
feedback and evaluation will be assessed for its potential
to set the foundations for how healthcare services are
routinely examined and optimised in the future.
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